Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Toussirot

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Rheumatology|September 3, 2018
Unilateral Accessory Sacroiliac Joint with Bone Marrow Edema Mimicking SacroiliitisEric Toussirot, Sébastien Aubry, Michel Runge
EULAR Rheumatology Open|June 29, 2026
Occurrence of amyotrophic lateral sclerosis during TNF inhibitor treatment in inflammatory rheumatic disease. What are the relationships?Eric Toussirot, Laurent Tatu, Matthieu Bereau
Frontiers in Immunology|January 22, 2026
Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume IIIEric Toussirot, Katarzyna Bogunia-Kubik, Philippe Saas
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?Eric Toussirot, Kashif Aziz Khan, Georges Herbein
Frontiers in Immunology|September 26, 2022
The cardiometabolic conditions of psoriatic diseaseEric Toussirot, Irène Gallais-Sérézal, François Aubin
Frontiers in Immunology|January 20, 2025
Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume IIKatarzyna Bogunia-Kubik, Philippe Saas, Eric Toussirot
Frontiers in Immunology|January 31, 2022
Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic DiseasesPhilippe Saas, Eric Toussirot, Katarzyna Bogunia-Kubik
Joint Bone Spine|October 27, 2006
Imaging study scores for ankylosing spondylitisDaniel Wendling, Eric Toussirot, Gérald Streit, et al.
Joint Bone Spine|February 23, 2010
Targeting intracellular signaling pathways to treat rheumatoid arthritis: Pandora's box?Daniel Wendling, Clément Prati, Eric Toussirot, et al.
Frontiers in Physiology|May 10, 2018
Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical EvidenceEric Toussirot, Matthieu Béreau, Charline Vauchy, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Rheumatology|September 3, 2018
Unilateral Accessory Sacroiliac Joint with Bone Marrow Edema Mimicking SacroiliitisEric Toussirot, Sébastien Aubry, Michel Runge
EULAR Rheumatology Open|June 29, 2026
Occurrence of amyotrophic lateral sclerosis during TNF inhibitor treatment in inflammatory rheumatic disease. What are the relationships?Eric Toussirot, Laurent Tatu, Matthieu Bereau
Frontiers in Immunology|January 22, 2026
Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume IIIEric Toussirot, Katarzyna Bogunia-Kubik, Philippe Saas
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?Eric Toussirot, Kashif Aziz Khan, Georges Herbein
Frontiers in Immunology|September 26, 2022
The cardiometabolic conditions of psoriatic diseaseEric Toussirot, Irène Gallais-Sérézal, François Aubin
Frontiers in Immunology|January 20, 2025
Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume IIKatarzyna Bogunia-Kubik, Philippe Saas, Eric Toussirot
Frontiers in Immunology|January 31, 2022
Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic DiseasesPhilippe Saas, Eric Toussirot, Katarzyna Bogunia-Kubik
Joint Bone Spine|October 27, 2006
Imaging study scores for ankylosing spondylitisDaniel Wendling, Eric Toussirot, Gérald Streit, et al.
Joint Bone Spine|February 23, 2010
Targeting intracellular signaling pathways to treat rheumatoid arthritis: Pandora's box?Daniel Wendling, Clément Prati, Eric Toussirot, et al.
Frontiers in Physiology|May 10, 2018
Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical EvidenceEric Toussirot, Matthieu Béreau, Charline Vauchy, et al.
Pageof 15